Latest Presentations
The following investment analysts currently provide research on ReNeuron:
- Analyst Broker Recommendation Price Target
Navid Malik Cenkos Securities Buy 22p
Robin Campbell Merchant Securities Buy 33p
Please click on link below for webcast of presentation by Michael Hunt, CEO at the 2011 Stem Cell on the Mesa Conference, La Jolla, CA, USA on 1st December 2011
Please click on link below for webcast of 2011 Interim Results presentation to analysts.
http://media.buchanan.uk.com/reneuron281111/index.html
Please click on link below for CNBC interview with Vadim Alexandre, Healthcare Analyst, Daniel Stewart
Updated research notes can be obtained via the following link:


